Fortune |
Pfizer Just Spent about $645 Million to Buy This Gene Therapy Company
Fortune It may be a risky move. Pfizer PFE 0.99% said it had acquired privately-held gene therapy developer Bamboo Therapeutics in a deal worth up to $645 million to boost its presence in the treatment of rare diseases. Research into gene therapy, which aims ... |
Pfizer Just Spent about $645 Million to Buy This Gene Therapy Company - Fortune
Read More
0 Response to "Pfizer Just Spent about $645 Million to Buy This Gene Therapy Company - Fortune"
Post a Comment